Preclinical Evaluation of Dose-Volume Effects and Lung Toxicity Occurring In and Out-of-Field

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki et al. · The Lancet Oncology · 2015 · 2K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific Issues

Søren M. Bentzen, Louis S. Constine, Joseph O. Deasy et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 1.2K citations · Full text

Medicine, Biostatistics, Clinical Sciences +15

Clinical dose–volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

Mary V. Graham, James A. Purdy, Bahman Emami et al. · International Journal of Radiation Oncology*Biology*Physics · 1999 · 1.2K citations

Medicine, Oncology, Radiation Oncology +12

A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group

Carlos A. Pérez, K. Stanley, P. Rubin et al. · Cancer · 1980 · 460 citations

Medicine, Oncology, Radiation Oncology +16

Tolerance of Normal Tissue to Therapeutic Radiation

Bahman Emami · Reports of Radiotherapy and Oncology · 2013 · 456 citations

Medicine, Oncology, Radiation Oncology +14